Published in Bull World Health Organ on January 01, 1960
Studies of Glucose-6-Phosphate Dehydrogenase Activity of Individual Erythrocytes: The Methemoglobin-Elution Test for Identification of Females Heterozygous for G6PD Deficiency. Am J Hum Genet (1965) 1.72
Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J (2012) 1.35
Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots. Malar J (2010) 1.23
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency. Sci Rep (2012) 1.16
Haemoglobinopathies in immigrant families. Postgrad Med J (1965) 1.14
The frequency of glucose-6-phosphate dehydrogenase deficiency in the newborns and adults in Kuwait. Am J Hum Genet (1966) 1.09
Incidence of glucose-6-phosphate dehydrogenase deficiency in Egypt. Am J Hum Genet (1966) 0.96
The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism. Bull World Health Organ (1967) 0.95
A NEW INHERITED ENZYMATIC DEFICIENCY OF HUMAN ERYTHROCYTES: 6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY. Am J Hum Genet (1964) 0.91
Lipid peroxidation and antioxidant enzymes activity in Plasmodium vivax malaria patients evolving with cholestatic jaundice. Malar J (2013) 0.84
The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria. Bull World Health Organ (1961) 0.84
THIAZIDE-INDUCED NEONATAL HAEMOLYSIS? Br Med J (1964) 0.83
Bilirubin and red cell metabolism in relation to neonatal jaundice. Postgrad Med J (1969) 0.81
PharmGKB summary: methylene blue pathway. Pharmacogenet Genomics (2013) 0.78
Frequency of glucose-6-phosphate dehydrogenase deficiency in relation to altitude: a malaria hypothesis. Bull World Health Organ (1980) 0.77
Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Jaundice. Arch Dis Child (1963) 0.76
Influence of Plasmodium vivax malaria on the relations between the osmotic stability of human erythrocyte membrane and hematological and biochemical variables. Parasitol Res (2013) 0.76
ENZYMES AND DRUG SENSITIVITY. GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY. Proc R Soc Med (1964) 0.76
Clinical applications of some recent studies of erythrocyte enzymes. Bull N Y Acad Med (1963) 0.75
Alpha thalassemia: five cases of hemoglobin H disease in three Oriental-Canadian families. Can Med Assoc J (1968) 0.75
Glucose-6-phosphate dehydrogenase deficiency in Canadian Negroes. Can Med Assoc J (1969) 0.75
Methemoglobin reduction and the inactive X hypothesis. Am J Hum Genet (1966) 0.75
alpha-Thalassaemia and hyperbilirubinaemia in G-6-PD-deficient newborns. Arch Dis Child (1980) 0.75
Frequency of Haemoglobin S and Glucose-6-Phosphate Dehydrogenase Deficiency in Southern Tanzania. Br Med J (1965) 0.75
Standardizing a method for clinical hemoglobinometry. U S Armed Forces Med J (1954) 5.62
Enzymatic deficiency in primaquine-sensitive erythrocytes. Science (1956) 5.39
The reduction of methaemoglobin in red blood cells and studies on the cause of idiopathic methaemoglobinaemia. Biochem J (1948) 3.56
The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. J Lab Clin Med (1955) 2.63
Erythrocyte metabolism. II. Glucose metabolism and pathways. J Lab Clin Med (1960) 2.02
The mechanism of glutathione destruction and protection in drug-sensitive and non-sensitive erythrocytes; in vitro studies. J Clin Invest (1957) 1.55
The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine. J Lab Clin Med (1955) 1.37
Acute hemolytic anemia in the newborn infant due to naphthalene poisoning: report of two cases, with investigations into the mechanism of the disease. Blood (1958) 1.24
Erythrocyte glucose-6-phosphate dehydrogenase activity and methemoglobin reduction. J Lab Clin Med (1959) 0.98
[Hemolytic erythrocytopathy caused by absence of glucose-6-phosphate dehydrogenase in red cells as a dominant hereditary factor]. Klin Wochenschr (1958) 0.94
Enzymatic deficiency in primaquine-sensitive erythrocytes. Science (1956) 5.39
The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. J Lab Clin Med (1955) 2.63
Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Arch Intern Med (1962) 2.52
Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ (1960) 2.50
THE BETA-GALACTOSIDE PERMEASE SYSTEM AND THE METABOLISM OF PHOSPHOLIPIDS IN ESCHERICHIA COLI. J Biol Chem (1965) 2.25
Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc (1950) 1.79
Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg. daily. Am J Trop Med Hyg (1953) 1.79
Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg (1953) 1.75
Toxicity of primaquine in Caucasians. J Am Med Assoc (1952) 1.74
Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis. JAMA (1962) 1.71
The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med (1954) 1.67
Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg (1953) 1.66
Toxicity of primaquine in Negroes. J Am Med Assoc (1952) 1.63
Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med (1955) 1.55
The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis. J Lab Clin Med (1954) 1.50
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND. Bull World Health Organ (1964) 1.48
ERYTHROCYTE GLUCOSE-6-PHOSPHATE DEHYDROGENASE IN CAUCASIANS: NEW INHERITED VARIANT. Science (1964) 1.41
The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine. J Lab Clin Med (1955) 1.37
Mass therapy of subclinical vivax malaria with primaquine. J Am Med Assoc (1952) 1.35
Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg (1953) 1.35
The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals. J Lab Clin Med (1954) 1.33
Biochemical and genetic aspects of primaquine-sensitive hemolytic anemia. Ann Intern Med (1958) 1.28
Cure of Korean vivax malaria with pamaquine and primaquine. J Am Med Assoc (1952) 1.27
The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). J Lab Clin Med (1955) 1.25
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM COLOMBIA, SOUTH AMERICA. Am J Trop Med Hyg (1963) 1.24
The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity. J Lab Clin Med (1955) 1.23
The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes. J Lab Clin Med (1954) 1.22
The influence of dietary protein intake on specific renal functions in normal man. J Lab Clin Med (1954) 1.21
The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity. J Lab Clin Med (1958) 1.12
The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes. J Lab Clin Med (1961) 1.09
STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM. Bull World Health Organ (1964) 1.07
The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes. J Lab Clin Med (1958) 1.06
Natural history of Korean vivax malaria after deliberate inoculation of human volunteers. J Lab Clin Med (1954) 1.03
The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes. J Lab Clin Med (1961) 1.02
The Chesson strain of Plasmodium vivax malaria; relationship between prepatent period, latent period and relapse rate. J Infect Dis (1947) 1.00
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND FALCIPARUM MALARIA. Am J Trop Med Hyg (1965) 1.00
A clinical study of primaquine (S. N. 13,272) in the treatment of malaria among the Miskito Indians of Nicaragua. Am J Trop Med Hyg (1953) 0.98
Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg (1961) 0.95
Biochemistry of hemolysis. Annu Rev Med (1962) 0.93
Korean vivax malaria. IV. Curative effect of 15 milligrams of primaquine daily for 7 days. Am J Trop Med Hyg (1953) 0.93
The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med (1954) 0.92
Coenzyme studies in primaquine-sensitive erythrocytes. Proc Soc Exp Biol Med (1958) 0.92
STUDIES ON THE CORRELATION OF THE GENETICALLY DETERMINED TRAIT, GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, WITH BEHAVIORAL MANIFESTATIONS IN SCHIZOPHRENIA. J Lab Clin Med (1963) 0.91
A NEW INHERITED ENZYMATIC DEFICIENCY OF HUMAN ERYTHROCYTES: 6-PHOSPHOGLUCONATE DEHYDROGENASE DEFICIENCY. Am J Hum Genet (1964) 0.91
A NEW INHERITED ABNORMALITY OF HUMAN ERYTHROCYTES: ELEVATED ERYTHROCYTIC ADENOSINE TRIPHOSPHATE. Biochem Biophys Res Commun (1965) 0.89
The hemolytic effect of primaquine. XV. Role of methemoglobin. J Lab Clin Med (1962) 0.89
HEMOLYTIC EFFECT OF PRIMAQUINE. XVII. HEXOKINASE ACTIVITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT AND NORMAL ERYTHROCYTES. J Lab Clin Med (1964) 0.85
Glucose-6-phosphate dehydrogenase deficiency: some biological implications. Trans Assoc Am Physicians (1960) 0.85
The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria. Bull World Health Organ (1961) 0.84
Physiological changes during perfusion of the isolated intestinal loop in chronic uremia. J Lab Clin Med (1952) 0.81
The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes. J Lab Clin Med (1959) 0.81
The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes. J Lab Clin Med (1961) 0.81
A RE-EVALUATION OF THE RELATIONSHIP BETWEEN GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AND THE BEHAVIORAL MANIFESTATIONS OF SCHIZOPHRENIA. J Lab Clin Med (1965) 0.78
A method of determining the specific renal functions of glomerular filtration, maximal tubular excretion (or reabsorption) and effective blood flow using a single injection of a single substance. J Lab Clin Med (1947) 0.78
HEXOKINASE ACTIVITY AS A FUNCTION OF AGE OF THE HUMAN ERYTHROCYTE. Nature (1963) 0.77
Subclinical diabetes mellitus in patients presenting with clinical chronic glomerulonephritis. Trans Assoc Am Physicians (1958) 0.76
Pentaquine (SN-13,276) a new antimalarial effective in reducing the relapse rate of vivax malaria. Proc Annu Meet Cent Soc Clin Res U S (1947) 0.75
Renal resistance in essential hypertension; relation to the effect of sympathectomy on blood pressure. Proc Soc Exp Biol Med (1948) 0.75
HEMOLYTIC EFFECT OF PRIMAQUINE. XVI. GLYOXALASE ACTIVITY OF PRIMAQUINE-SENSITIVE AND NORMAL ERYTHROCYTES. J Lab Clin Med (1964) 0.75
ACTIVE IMMUNIZATION AGAINST MALARIA. Am J Trop Med Hyg (1964) 0.75
Toxicity studies of pyrimethamine (daraprim). Am J Trop Med Hyg (1955) 0.75
Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria. Abstr Int Congr Trop Med Malar (1948) 0.75
The clinical trial of 18 analogues of pamaquin (plasmochin) in vivax malaria, Chesson strain. J Clin Invest (1948) 0.75
A study of the prophylactic, curative and suppressive activity of SN-11,437 (metachloridine) in standardized infections of vivax malaria. Am J Trop Med Hyg (1948) 0.75
A clinical test for galactosemia. The galactose-methemoglobin test. Am J Clin Pathol (1963) 0.75
Procedures used at Stateville penitentiary for the testing of potential antimalarial agents. J Clin Invest (1948) 0.75
A clinical method of determining the specific renal functions of glomerular filtration, maximal tubular excretion or reabsorption (and effective blood flow) using a single injection of a single substance. Proc Annu Meet Cent Soc Clin Res U S (1945) 0.75
Pentaquine (SN-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria. J Clin Invest (1948) 0.75
The relation of renal to non-renal vascular resistances in essential hypertension; and the effect of sympathectomy. J Clin Invest (1948) 0.75
A review of the best new antimalarial drugs. Whats New (1950) 0.75
Studies on the chronic toxicity of chloroquine (SN-7618). J Clin Invest (1948) 0.75
Alterations of cerebral functions in pheochromocytoma. Neurology (1951) 0.75
A clinical method of determining the specific renal functions of glomerular filtration and maximal tubular excretion, or reabsorption (and effective blood flow), using a single injection of a single substance. J Lab Clin Med (1946) 0.75
Malignant hypertension. Med Clin North Am (1951) 0.75
[Phosphoglycerylaldehyde dehydrogenase activity in aging human erythrocytes]. Klin Wochenschr (1963) 0.75